426 related articles for article (PubMed ID: 14523281)
1. Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival.
Staehelin C; Rickenbach M; Low N; Egger M; Ledergerber B; Hirschel B; D'Acremont V; Battegay M; Wagels T; Bernasconi E; Kopp C; Furrer H;
AIDS; 2003 Oct; 17(15):2237-44. PubMed ID: 14523281
[TBL] [Abstract][Full Text] [Related]
2. Migrants from sub-Saharan Africa in the Swiss HIV Cohort Study: a single center study of epidemiologic migration-specific and clinical features.
Staehelin C; Egloff N; Rickenbach M; Kopp C; Furrer H;
AIDS Patient Care STDS; 2004 Nov; 18(11):665-75. PubMed ID: 15635749
[TBL] [Abstract][Full Text] [Related]
3. Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study.
Thierfelder C; Weber R; Elzi L; Furrer H; Cavassini M; Calmy A; Bernasconi E; Gutmann C; Ledergerber B;
HIV Med; 2012 Feb; 13(2):118-26. PubMed ID: 22107170
[TBL] [Abstract][Full Text] [Related]
4. Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.
Pantazis N; Morrison C; Amornkul PN; Lewden C; Salata RA; Minga A; Chipato T; Jaffe H; Lakhi S; Karita E; Porter K; Meyer L; Touloumi G;
PLoS One; 2012; 7(3):e32369. PubMed ID: 22412867
[TBL] [Abstract][Full Text] [Related]
5. CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care-a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999-2013.
Zeitlmann N; Gunsenheimer-Bartmeyer B; Santos-Hövener C; Kollan C; An der Heiden M;
BMC Infect Dis; 2016 Dec; 16(1):739. PubMed ID: 27927190
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
May M; Boulle A; Phiri S; Messou E; Myer L; Wood R; Keiser O; Sterne JA; Dabis F; Egger M;
Lancet; 2010 Aug; 376(9739):449-57. PubMed ID: 20638120
[TBL] [Abstract][Full Text] [Related]
7. Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France.
de Monteynard LA; Matheron S; Grabar S; de Truchis P; Gilquin J; Pavie J; Launay O; Meynard JL; Khuong-Josses MA; Rey D; Mahamat A; Dray-Spira R; Simon A; Costagliola D; Abgrall S;
PLoS One; 2018; 13(10):e0205385. PubMed ID: 30379870
[TBL] [Abstract][Full Text] [Related]
8. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review.
Barth RE; van der Loeff MF; Schuurman R; Hoepelman AI; Wensing AM
Lancet Infect Dis; 2010 Mar; 10(3):155-66. PubMed ID: 20185094
[TBL] [Abstract][Full Text] [Related]
9. Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa.
Egger M; Ekouevi DK; Williams C; Lyamuya RE; Mukumbi H; Braitstein P; Hartwell T; Graber C; Chi BH; Boulle A; Dabis F; Wools-Kaloustian K
Int J Epidemiol; 2012 Oct; 41(5):1256-64. PubMed ID: 21593078
[No Abstract] [Full Text] [Related]
10. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
[TBL] [Abstract][Full Text] [Related]
11. Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study.
Staehelin C; Keiser O; Calmy A; Weber R; Elzi L; Cavassini M; Schmid P; Bernasconi E; Furrer H;
J Acquir Immune Defic Syndr; 2012 Jan; 59(1):79-85. PubMed ID: 21937923
[TBL] [Abstract][Full Text] [Related]
12. Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy.
Peterson K; van Griensven J; Huis in 't Veld D; Colebunders R
Expert Rev Anti Infect Ther; 2012 Jan; 10(1):43-50. PubMed ID: 22149613
[TBL] [Abstract][Full Text] [Related]
13. AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.
Anglaret X; Minga A; Gabillard D; Ouassa T; Messou E; Morris B; Traore M; Coulibaly A; Freedberg KA; Lewden C; Ménan H; Abo Y; Dakoury-Dogbo N; Toure S; Seyler C;
Clin Infect Dis; 2012 Mar; 54(5):714-23. PubMed ID: 22173233
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
[TBL] [Abstract][Full Text] [Related]
15. Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France.
de Monteynard LA; Matheron S; Gilquin J; Pavie J; de Truchis P; Grabar S; Launay O; Meynard JL; Khuong-Josses MA; Rey D; Simon A; Mahamat A; Dray-Spira R; Costagliola D; Abgrall S;
AIDS; 2016 Sep; 30(14):2235-46. PubMed ID: 27428741
[TBL] [Abstract][Full Text] [Related]
16. Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.
Gabillard D; Lewden C; Ndoye I; Moh R; Segeral O; Tonwe-Gold B; Etard JF; Pagnaroat M; Fournier-Nicolle I; Eholié S; Konate I; Minga A; Mpoudi-Ngole E; Koulla-Shiro S; Zannou DM; Anglaret X; Laurent C;
J Acquir Immune Defic Syndr; 2013 Apr; 62(5):555-61. PubMed ID: 23274931
[TBL] [Abstract][Full Text] [Related]
17. Lack of appropriate treatment for people with comorbid HIV/AIDS and epilepsy in sub-Saharan Africa.
Birbeck G; Chomba E; Ddumba E; Kauye F; Mielke J
Epilepsia; 2007 Jul; 48(7):1424-5. PubMed ID: 17635568
[No Abstract] [Full Text] [Related]
18. The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.
; Slogrove AL; Schomaker M; Davies MA; Williams P; Balkan S; Ben-Farhat J; Calles N; Chokephaibulkit K; Duff C; Eboua TF; Kekitiinwa-Rukyalekere A; Maxwell N; Pinto J; Seage G; Teasdale CA; Wanless S; Warszawski J; Wools-Kaloustian K; Yotebieng M; Timmerman V; Collins IJ; Goodall R; Smith C; Patel K; Paul M; Gibb D; Vreeman R; Abrams EJ; Hazra R; Van Dyke R; Bekker LG; Mofenson L; Vicari M; Essajee S; Penazzato M; Anabwani G; Q Mohapi E; N Kazembe P; Hlatshwayo M; Lumumba M; Goetghebuer T; Thorne C; Galli L; van Rossum A; Giaquinto C; Marczynska M; Marques L; Prata F; Ene L; Okhonskaia L; Rojo P; Fortuny C; Naver L; Rudin C; Le Coeur S; Volokha A; Rouzier V; Succi R; Sohn A; Kariminia A; Edmonds A; Lelo P; Ayaya S; Ongwen P; Jefferys LF; Phiri S; Mubiana-Mbewe M; Sawry S; Renner L; Sylla M; Abzug MJ; Levin M; Oleske J; Chernoff M; Traite S; Purswani M; Chadwick EG; Judd A; Leroy V
PLoS Med; 2018 Mar; 15(3):e1002514. PubMed ID: 29494593
[TBL] [Abstract][Full Text] [Related]
19. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
Bwire R; Nagelkerke NJ; Borgdorff MW
Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
[TBL] [Abstract][Full Text] [Related]
20. Disease progression and survival in HIV-1-infected Africans in London.
Del Amo J; Petruckevitch A; Phillips A; Johnson AM; Stephenson J; Desmond N; Hanscheid T; Low N; Newell A; Obasi A; Paine K; Pym A; Theodore CM; De Cock KM
AIDS; 1998 Jul; 12(10):1203-9. PubMed ID: 9677170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
